Orthopedic Implant Market

Growing orthopedic implant innovation to boost market growth

The rise in orthopedic surgeries has led to an increase in the demand for bone implants. Implants can now be tailored because of the rising need for implantable medical devices, as each patient confronts the surgeon with a different set of challenges. Additionally, personalization enables the orthopedic specialist to insert an implant using a variety of techniques. Artificial intelligence (AI)-driven guidance software, portable navigation to guide the surgeon during the implant, and robotic orthopedic surgery performed fully remotely will all find growing commercial use.

Additionally, 3D printing to manufacture specialty implants to make a multi-layered composite implant is one of the primary orthopedic implant market trends in the production of these devices. This is because different important players have invested, and the technology enables for customization.

In addition, Health Canada approved the first 3D-printed implant-specific mandibular plate produced domestically in December 2021. The (LARA 3D), a division of Investissement Québec (CREEK) with headquarters in Quebec City, created the implant. The market is expected to be expand by the worldwide support governments give to domestic manufacturing and the development of cutting-edge medical products like implants.

Geriatrics are considered a viable patient population for orthopedic implants because of the increased risk of bone diseases, fractures, and bone porosity as people age. According to a report by MDPI medicine 2021, the elderly have a higher risk of fractures, with a chance of 40–50% for women and 13–22% for males as they age. Additionally, according to a World Health Organization (WHO) article from 2021, the number of older adults worldwide is expected to rise from 1 billion to 1.4 billion by 2030. Furthermore, throughout this time, 1 in 6 people is anticipated to reach 60.

Therefore, this condition has recently enhanced the market of Orthopedic Implants CAGR.

However, a sharp increase in road accidents and sports-related injuries are projected to spur market expansion, another factor driving the growth of the Orthopedic Implants market revenue.

The Global Orthopedic Implants Market Industry is poised for substantial growth, with projections indicating a market value of 55.0 USD Billion in 2024 and an anticipated increase to 99.1 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate (CAGR) of 5.49% from 2025 to 2035. Such figures reflect the increasing demand for orthopedic solutions driven by various factors, including an aging population, rising prevalence of orthopedic disorders, and advancements in implant technology. The market's expansion is indicative of the ongoing need for innovative and effective orthopedic implants to address the evolving healthcare landscape.

The demographic shift towards an aging population, coupled with lifestyle changes, significantly impacts the Global Orthopedic Implants Market Industry. Older adults are more susceptible to orthopedic conditions due to natural wear and tear on joints. Additionally, sedentary lifestyles and increased obesity rates contribute to a higher prevalence of joint-related issues. This demographic trend is expected to drive the demand for orthopedic implants, as more individuals require surgical interventions to maintain mobility and quality of life. The convergence of these factors suggests a sustained growth trajectory for the market, aligning with the projected figures for the coming years.

The increasing incidence of orthopedic disorders, such as osteoarthritis and osteoporosis, drives the Global Orthopedic Implants Market Industry. As populations age, the demand for joint replacement surgeries rises significantly. For instance, the World Health Organization indicates that by 2024, the market is projected to reach 55.0 USD Billion, reflecting the urgent need for effective orthopedic solutions. This trend is likely to continue as the global population ages, with projections suggesting that by 2035, the market could expand to 99.1 USD Billion. Such growth underscores the necessity for innovative orthopedic implants to address these prevalent conditions.

Technological innovations in the design and manufacturing of orthopedic implants are pivotal for the Global Orthopedic Implants Market Industry. Advances in materials science, such as the development of biocompatible materials and 3D printing technologies, enhance the performance and longevity of implants. These innovations not only improve surgical outcomes but also reduce recovery times for patients. For example, the introduction of patient-specific implants tailored to individual anatomies demonstrates a shift towards personalized medicine in orthopedics. This trend is expected to contribute to the market's growth, as it aligns with the increasing demand for customized healthcare solutions.

The expansion of healthcare infrastructure globally significantly influences the Global Orthopedic Implants Market Industry. Governments and private sectors are investing in modernizing hospitals and surgical centers, which facilitates the adoption of advanced orthopedic technologies. Enhanced surgical facilities enable more complex procedures, including minimally invasive surgeries, which are becoming increasingly popular. This investment is particularly evident in emerging economies, where healthcare access is improving. As a result, the market is likely to experience robust growth, with a projected CAGR of 5.49% from 2025 to 2035, driven by the rising number of surgical procedures performed.

Raising awareness about orthopedic health and preventive measures plays a crucial role in the Global Orthopedic Implants Market Industry. Educational campaigns and initiatives by health organizations aim to inform the public about the importance of early diagnosis and treatment of orthopedic conditions. This increased awareness leads to higher rates of consultations and, consequently, more surgical interventions. For instance, community health programs that focus on physical activity and injury prevention can reduce the incidence of orthopedic disorders. As more individuals seek medical advice, the demand for orthopedic implants is expected to rise, further propelling market growth.

Major market companies are investing a lot of money in R&D to expand their product portfolios, which will spur further growth in the orthopedic implants market. With significant key development like new product releases, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations, market participants are also undertaking various strategic activities to expand their presence. Orthopedic Implants industry competitors must provide affordable products to grow and compete in a more cutthroat and competitive market climate.

Manufacturing locally to cut operating costs is one of the leading business tactics manufacturers use in the Orthopedic Implants industry to benefit customers and increase the market sector. In recent years, the Orthopedic Implants industry has provided medicine with some of the most significant benefits. Major companies in the orthopedic implants industry, including DePuy Synthes (Johnson & Johnson Services, Inc.), Zimmer Biomet,Smith & Nephew, and others, are attempting to increase market demand by funding R&D initiatives..

Smith & Nephew plc, usually called Smith+Nephew, is a British multinational medical equipment manufacturer with its headquarters in Watford, England. In November 2021, Smith and Nephew unveiled a total knee system without cement. Conceloc Advanced Porous Titanium, a proprietary material patented for 3D printing, is used to make the implant. The porous nature of the implant encourages bone ingrowth.

Also, LimaCorporate manufactures medical equipment. Large Joint Primary and Revision Implants, Extremities and Fixation Solutions, and a patient-specific prosthesis division are all part of their product line.

In March 2022, the successful insertion of ProVide, a patient-specific 3D printed implant, by Ortho Carolina Center in New York City, United States, was the catalyst for a partnership between LimaCorporate S.p.A. and Ortho. The development highlights the advantages of on-site implant development in conjunction with surgeons' knowledge, including shorter surgery times and patient-specific implant personalization.